Iolyx Therapeutics
PrivateLast Round
Series B
Dec 3, 2025
Total Funding Raised
$45M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Iolyx Therapeutics is a biotechnology company that develops targeted immunomodulatory therapies for ocular inflammatory and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Iolyx Therapeutics Comparables
Compare Iolyx Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stuart Therapeutics, Inc. | 87% | |
| TearSolutions | 87% | |
| Selagine, Inc. | 83% | |
Iolyx Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 3, 2025 | ||||
| Series A | Apr 20, 2023 |
Iolyx Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Frazier Healthcare Partners | Series A |
| Frazier Life Sciences | Series B |
| Cooley | Series B |
| Alumni Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 3, 2025
$15M round completed.
- Dec 3, 2025
Partnering with Laboratoires Théa for autoimmune dry eye treatment.
Iolyx Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Iolyx Therapeutics's valuation, stock price, and market status.